Literature DB >> 20951316

Solid tumors associated with multiple endocrine neoplasias.

Madson Q Almeida1, Constantine A Stratakis.   

Abstract

We present an update on molecular and clinical genetics of solid tumors associated with the various multiple endocrine neoplasias (MEN) syndromes. MEN type 1 (MEN1) describes the association of pituitary, parathyroid, and pancreatic islet cell tumors with a variety of many other lesions. MEN type 2 (MEN2) conditions represent at least four different syndromes that associate pheochromocytoma with medullary thyroid carcinoma, hyperparathyroidism, and a number of other manifestations. Other pheochromocytoma-associated syndromes include von Hippel-Lindau disease; neurofibromatosis 1; the recently defined paraganglioma syndromes type 1, 3, and 4; Carney-Stratakis syndrome; and the Carney triad. Carney-Stratakis syndrome is characterized by the association of paragangliomas and familial gastrointestinal stromal tumors. In the Carney triad, patients can manifest gastrointestinal stromal tumors, lung chondroma, paraganglioma, adrenal adenoma and pheochromocytoma, esophageal leiomyoma, and other conditions. The Carney complex is yet another form of MEN that is characterized by skin tumors and pigmented lesions, myxomas, schwannomas, and various endocrine neoplasias.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20951316      PMCID: PMC2957471          DOI: 10.1016/j.cancergencyto.2010.09.006

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  63 in total

1.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.

Authors:  B E Baysal; R E Ferrell; J E Willett-Brozick; E C Lawrence; D Myssiorek; A Bosch; A van der Mey; P E Taschner; W S Rubinstein; E N Myers; C W Richard; C J Cornelisse; P Devilee; B Devlin
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

2.  Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma.

Authors:  M M Walther; R Reiter; H R Keiser; P L Choyke; D Venzon; K Hurley; J R Gnarra; J C Reynolds; G M Glenn; B Zbar; W M Linehan
Journal:  J Urol       Date:  1999-09       Impact factor: 7.450

3.  Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.

Authors:  D Astuti; F Latif; A Dallol; P L Dahia; F Douglas; E George; F Sköldberg; E S Husebye; C Eng; E R Maher
Journal:  Am J Hum Genet       Date:  2001-06-12       Impact factor: 11.025

Review 4.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

5.  Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.

Authors:  L S Kirschner; J A Carney; S D Pack; S E Taymans; C Giatzakis; Y S Cho; Y S Cho-Chung; C A Stratakis
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

6.  Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex.

Authors:  L S Kirschner; F Sandrini; J Monbo; J P Lin; J A Carney; C A Stratakis
Journal:  Hum Mol Genet       Date:  2000-12-12       Impact factor: 6.150

Review 7.  The GDNF/RET signaling pathway and human diseases.

Authors:  M Takahashi
Journal:  Cytokine Growth Factor Rev       Date:  2001-12       Impact factor: 7.638

Review 8.  Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation.

Authors:  C A Stratakis; L S Kirschner; J A Carney
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

9.  Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex).

Authors:  S D Pack; L S Kirschner; E Pak; Z Zhuang; J A Carney; C A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

10.  Mutations in SDHC cause autosomal dominant paraganglioma, type 3.

Authors:  S Niemann; U Müller
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

View more
  13 in total

Review 1.  What Have We Learned from Molecular Biology of Paragangliomas and Pheochromocytomas?

Authors:  Thomas G Papathomas; Diederik P D Suurd; Alfred K Lam; Ronald R de Krijger; Karel Pacak; Arthur S Tischler; Menno R Vriens
Journal:  Endocr Pathol       Date:  2021-01-12       Impact factor: 3.943

2.  A Calcitonin-Negative Neuroendocrine Tumor Derived from Follicular Lesions of the Thyroid.

Authors:  Ga Young Kim; Chul Yun Park; Chang Ho Cho; June Sik Park; Eui Dal Jung; Eon Ju Jeon
Journal:  Endocrinol Metab (Seoul)       Date:  2014-12-09

Review 3.  Hereditary syndromes predisposing to endocrine tumors and their skin manifestations.

Authors:  Constantine A Stratakis
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

4.  Association of carcinoid tumor and low grade glioma.

Authors:  Emeline Tabouret; Maryline Barrié; Cecile Vicier; Anthony Gonçalves; Olivier Chinot; Patrice Viens; Anne Madroszyk
Journal:  World J Surg Oncol       Date:  2012-11-08       Impact factor: 2.754

5.  Chemical genetic discovery of targets and anti-targets for cancer polypharmacology.

Authors:  Arvin C Dar; Tirtha K Das; Kevan M Shokat; Ross L Cagan
Journal:  Nature       Date:  2012-06-06       Impact factor: 49.962

6.  Pancreatic endocrine tumors.

Authors:  Ake Andrén-Sandberg
Journal:  N Am J Med Sci       Date:  2011-04

7.  Multiple Endocrine Neoplasia Type 1: A Case Report With Review of Imaging Findings.

Authors:  Hilary R Keller; Jessica L Record; Neil U Lall
Journal:  Ochsner J       Date:  2018

Review 8.  Pituitary tumors in patients with MEN1 syndrome.

Authors:  Luis V Syro; Bernd W Scheithauer; Kalman Kovacs; Rodrigo A Toledo; Francisco J Londoño; Leon D Ortiz; Fabio Rotondo; Eva Horvath; Humberto Uribe
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

9.  Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort.

Authors:  Judit Dénes; Francesca Swords; Eleanor Rattenberry; Karen Stals; Martina Owens; Treena Cranston; Paraskevi Xekouki; Linda Moran; Ajith Kumar; Christopher Wassif; Naomi Fersht; Stephanie E Baldeweg; Damian Morris; Stafford Lightman; Amar Agha; Aled Rees; Joan Grieve; Michael Powell; Cesar Luiz Boguszewski; Pinaki Dutta; Rajesh V Thakker; Umasuthan Srirangalingam; Chris J Thompson; Maralyn Druce; Claire Higham; Julian Davis; Rosalind Eeles; Mark Stevenson; Brendan O'Sullivan; Phillipe Taniere; Kassiani Skordilis; Plamena Gabrovska; Anne Barlier; Susan M Webb; Anna Aulinas; William M Drake; John S Bevan; Cristina Preda; Nadezhda Dalantaeva; Antônio Ribeiro-Oliveira; Isabel Tena Garcia; Galina Yordanova; Violeta Iotova; Jane Evanson; Ashley B Grossman; Jacqueline Trouillas; Sian Ellard; Constantine A Stratakis; Eamonn R Maher; Federico Roncaroli; Márta Korbonits
Journal:  J Clin Endocrinol Metab       Date:  2014-12-12       Impact factor: 5.958

10.  Association Between Kidney Stones and Risk of Stroke: A Nationwide Population-Based Cohort Study.

Authors:  Shih-Yi Lin; Cheng-Li Lin; Yen-Jung Chang; Wu-Huei Hsu; Cheng-Chieh Lin; I-Kuan Wang; Chiz-Tzung Chang; Chao-Hsiang Chang; Ming-Chia Lin; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.